Polygenic scores for major depression, schizophrenia and bipolar disorder have been related to treatment outcome. We analysed 4,007 patients of European ancestry from 7 cohorts: three with major depression (STAR*D, GSRD, PANDORA), two with bipolar disorder (STEP-BD, Barcelona) and two with schizophrenia (CATIE, HSRRm)....
A. Serretti, D. Souery, S. Kasper et al.· medRxiv· 0 citations
Alzheimer's disease (AD) is the most common cause of dementia, with global case numbers projected to reach 153 million in 20501. AD is highly heritable, with twin-based heritability estimates of 60-80%2. Although 1,200 causal loci are predicted to exist for AD3, approximately 80 loci have been associated with AD in two...
E. Uffelmann, D. Wightman, S. Bahrami et al.· Nature· 0 citations
Remission in major depressive disorder (MDD) is conventionally defined as a 17-item Hamilton Depression Rating Scale (HAMD-17) score ≤7, but patients within this range may retain residual symptoms. We explored whether complete remission (HAMD-17 <4) and partial remission (HAMD-17 4-7) differ in baseline clinical featur...
A. Serretti, A. Minelli, D. Souery et al.· European Neuropsychopharmaco...· 0 citations
Despite decades of extensive research, the complex architecture underlying human brain signaling remains incompletely understood. Previous work investigating the relationship between brain glucose metabolism and functional connectivity (FC) employed whole-brain analysis, without accounting for network interactions, dep...
Sarah M. Tüchler, P. Falb, C. Milz et al.· bioRxiv· 0 citations
Abstract Background Transcranial focused ultrasound stimulation (TUS) is emerging as a promising method for non-invasive and safe modulation of neuronal activity throughout the human brain [1]. Although several centers worldwide have started to investigate TUS in patient collectives, dosing of sonication parameters rem...
G. Godbersen, M. Lückel, C. Milz et al.· International Journal of Neu...· 0 citations
Understanding of the genetic architecture of AD in the context of its main genetic driver is improved, and APOE-stratified insights may help understand and overcome side effects, inform clinical trial enrollment strategies, and create the scientific basis for targeted, mechanism-driven therapies in neurodegenerative di...
J. Thomassen, H. Leonard, Brittany Ulms et al.· Nature Genetics· 0 citations
Abstract Background Electroconvulsive therapy (ECT) is among the most effective treatments for severe and treatment-resistant depression. Despite more than 90 years of clinical use, its underlying neurobiological mechanisms remain incompletely understood. One prominent hypothesis suggests that ECT induces neuroplastic...
P. Baldinger-Melich, S. Riessland, B. Spurny-Dworak et al.· International Journal of Neu...· 0 citations
Despite great progress on case–control polygenic prediction, an unmet need remains for a method that genetically distinguishes clinically related disorders (e.g., schizophrenia (SCZ) versus bipolar disorder (BIP) versus major depressive disorder (MDD) versus controls). We introduce differential diagnosis–polygenic risk...
W. Peyrot, G. Panagiotaropoulou, L. O. Olde Loohuis et al.· Nature Genetics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.